DR. AMY VALENTY SCHMETZER DNP, FNP-C
Prescription History 1083178826
Nurse Practitioner - Critical Care Medicine in Pittsburgh, PA

Active since January 25, 2019PECOS EnrolledAccepts Medicare Assignment
93.78/100
CMS Quality Rating
490 E NORTH AVE STE 309, PITTSBURGH, PA 15212(412) 442-2522(412) 442-2524 Get Directions

NPPES record last updated: November 17, 2023. Verified against the NPPES registry weekly; last sync: October 04, 2026.

Record update history: Nov 17, 2023, Oct 7, 2020, Sep 23, 2019 and 1 more (4 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. AMY VALENTY SCHMETZER DNP, FNP-C, an active Critical Care Medicine specialist practicing in Pittsburgh, PA. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 638 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 110 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

18
Medications
638
Total Claims
815
30-Day Fills
Trelegy Ellipta
Most Prescribed · 110 claims
View details
18 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. AMY VALENTY SCHMETZER DNP, FNP-C in 2023, with prescription volumes, average cost per fill, and PA state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other PA PrescribersVs. PA Avg

About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed.

In 2023, this provider wrote 110 Medicare prescriptions for Trelegy Ellipta, about 2.1 times the volume of the typical Pennsylvania prescriber of this medication (53). Medicare paid an average of $825.57 per fill, versus $788.36 statewide.

How often this provider prescribes it

This provider
110
PA average
53.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$825.57
PA average
$788.36

Gross Part D cost per fill; not the patient's out-of-pocket price.

136
30-Day Fills
standardized to 30-day supplies
4,080
Days of Medication
total across all patients in 2023

About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾

It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.

In 2023, this provider wrote 93 Medicare prescriptions for Albuterol Sulfate Hfa, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (59). Medicare paid an average of $36.45 per fill, versus $49.09 statewide.

How often this provider prescribes it

This provider
93
PA average
59.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$36.45
PA average
$49.09

This provider's average cost per fill is below the PA average for this medication.

107.2
30-Day Fills
standardized to 30-day supplies
2,336
Days of Medication
total across all patients in 2023

About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾

Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms.

In 2023, this provider wrote 75 Medicare prescriptions for Azelastine Hcl, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $31.16 per fill, versus $42.70 statewide.

How often this provider prescribes it

This provider
75
PA average
33.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$31.16
PA average
$42.70

This provider's average cost per fill is below the PA average for this medication.

128.1
30-Day Fills
standardized to 30-day supplies
3,825
Days of Medication
total across all patients in 2023

About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾

This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 57 Medicare prescriptions for Breo Ellipta, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (37). Medicare paid an average of $459.15 per fill, versus $497.99 statewide.

How often this provider prescribes it

This provider
57
PA average
37.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$459.15
PA average
$497.99

This provider's average cost per fill is below the PA average for this medication.

66
30-Day Fills
standardized to 30-day supplies
1,980
Days of Medication
total across all patients in 2023

About Fluticasone Propionate: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾

Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.

In 2023, this provider wrote 39 Medicare prescriptions for Fluticasone Propionate, about 72% of the volume of the typical Pennsylvania prescriber of this medication (54). Medicare paid an average of $9.34 per fill, versus $15.15 statewide.

How often this provider prescribes it

This provider
39
PA average
54.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.34
PA average
$15.15

This provider's average cost per fill is below the PA average for this medication.

53
30-Day Fills
standardized to 30-day supplies
1,590
Days of Medication
total across all patients in 2023

About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2023, this provider wrote 38 Medicare prescriptions for Symbicort, about 1.3 times the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $442.50 per fill, versus $498.01 statewide.

How often this provider prescribes it

This provider
38
PA average
30.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$442.50
PA average
$498.01

This provider's average cost per fill is below the PA average for this medication.

46
30-Day Fills
standardized to 30-day supplies
1,380
Days of Medication
total across all patients in 2023

About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾

Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

In 2023, this provider wrote 34 Medicare prescriptions for Prednisone, about 71% of the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $2.55 per fill, versus $5.96 statewide.

How often this provider prescribes it

This provider
34
PA average
48.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2.55
PA average
$5.96

This provider's average cost per fill is below the PA average for this medication.

36
30-Day Fills
standardized to 30-day supplies
286
Days of Medication
total across all patients in 2023

About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾

It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways.

In 2023, this provider wrote 34 Medicare prescriptions for Montelukast Sodium, about 61% of the volume of the typical Pennsylvania prescriber of this medication (56). Medicare paid an average of $10.03 per fill, versus $17.17 statewide.

How often this provider prescribes it

This provider
34
PA average
56.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$10.03
PA average
$17.17

This provider's average cost per fill is below the PA average for this medication.

54
30-Day Fills
standardized to 30-day supplies
1,620
Days of Medication
total across all patients in 2023

About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾

This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

In 2023, this provider wrote 23 Medicare prescriptions for Famotidine, about 70% of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $11.25 per fill, versus $10.26 statewide.

How often this provider prescribes it

This provider
23
PA average
33.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$11.25
PA average
$10.26

Gross Part D cost per fill; not the patient's out-of-pocket price.

39
30-Day Fills
standardized to 30-day supplies
1,170
Days of Medication
total across all patients in 2023

About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾

It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

In 2023, this provider wrote 19 Medicare prescriptions for Omeprazole, about 17% of the volume of the typical Pennsylvania prescriber of this medication (109). Medicare paid an average of $10.70 per fill, versus $14.36 statewide.

How often this provider prescribes it

This provider
19
PA average
109.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$10.70
PA average
$14.36

This provider's average cost per fill is below the PA average for this medication.

25
30-Day Fills
standardized to 30-day supplies
750
Days of Medication
total across all patients in 2023

About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma.

In 2023, this provider wrote 18 Medicare prescriptions for Breztri Aerosphere, about 60% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $624.80 per fill, versus $739.39 statewide.

How often this provider prescribes it

This provider
18
PA average
30.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$624.80
PA average
$739.39

This provider's average cost per fill is below the PA average for this medication.

18
30-Day Fills
standardized to 30-day supplies
540
Days of Medication
total across all patients in 2023

About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.

In 2023, this provider wrote 17 Medicare prescriptions for Anoro Ellipta, about half the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $497.37 per fill, versus $560.38 statewide.

How often this provider prescribes it

This provider
17
PA average
34.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$497.37
PA average
$560.38

This provider's average cost per fill is below the PA average for this medication.

17
30-Day Fills
standardized to 30-day supplies
510
Days of Medication
total across all patients in 2023

About Azithromycin: This medication is used to treat certain eye infections. Show more ▾

It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

In 2023, this provider wrote 17 Medicare prescriptions for Azithromycin, about half the volume of the typical Pennsylvania prescriber of this medication (35). Medicare paid an average of $4.79 per fill, versus $8.15 statewide.

How often this provider prescribes it

This provider
17
PA average
35.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$4.79
PA average
$8.15

This provider's average cost per fill is below the PA average for this medication.

19
30-Day Fills
standardized to 30-day supplies
166
Days of Medication
total across all patients in 2023

About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.

In 2023, this provider wrote 15 Medicare prescriptions for Stiolto Respimat, about half the volume of the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $614.51 per fill, versus $594.31 statewide.

How often this provider prescribes it

This provider
15
PA average
27.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$614.51
PA average
$594.31

Gross Part D cost per fill; not the patient's out-of-pocket price.

19
30-Day Fills
standardized to 30-day supplies
570
Days of Medication
total across all patients in 2023

About Ventolin Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾

It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.

In 2023, this provider wrote 15 Medicare prescriptions for Ventolin Hfa, about half the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $65.47 per fill, versus $72.61 statewide.

How often this provider prescribes it

This provider
15
PA average
28.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$65.47
PA average
$72.61

This provider's average cost per fill is below the PA average for this medication.

17.2
30-Day Fills
standardized to 30-day supplies
365
Days of Medication
total across all patients in 2023

About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾

Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease.

In 2023, this provider wrote 12 Medicare prescriptions for Ofev, about a third of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $12,696.27 per fill, versus $12,060.82 statewide.

How often this provider prescribes it

This provider
12
PA average
30.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12,696.27
PA average
$12,060.82

Gross Part D cost per fill; not the patient's out-of-pocket price.

12
30-Day Fills
standardized to 30-day supplies
360
Days of Medication
total across all patients in 2023

About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾

It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2023, this provider wrote 11 Medicare prescriptions for Incruse Ellipta, about half the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $493.25 per fill, versus $436.36 statewide.

How often this provider prescribes it

This provider
11
PA average
26.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$493.25
PA average
$436.36

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2023

About Nucala: This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾

Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab is also used to treat certain other immune system disorders (chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome). This medication works by decreasing a certain type of white blood cell (eosinophils). This effect helps reduce swelling (inflammation) of the airways to make breathing easier. It may also help reduce the size of nasal polyps, and lessen symptoms such as runny/stuffy nose, mucus in the throat, loss of smell, facial pain, and tiredness. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

In 2023, this provider wrote 11 Medicare prescriptions for Nucala, about half the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $3,707.88 per fill, versus $4,041.83 statewide.

How often this provider prescribes it

This provider
11
PA average
21.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3,707.88
PA average
$4,041.83

This provider's average cost per fill is below the PA average for this medication.

11
30-Day Fills
standardized to 30-day supplies
308
Days of Medication
total across all patients in 2023
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average PA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the PA average cost per fill.

About this data. The prescription history for DR. AMY VALENTY SCHMETZER DNP, FNP-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Critical Care Medicine prescribing approach at this Pittsburgh, PA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.